Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.
Open Forum Infect Dis
; 9(8): ofac382, 2022 Aug.
Article
em En
| MEDLINE
| ID: mdl-36039098
ABSTRACT
Persistent severe acute respiratory syndrome coronavirus 2 infection is difficult to treat. Here, we report a case of 5-month persistent coronavirus disease 2019 in an immunocompromised patient who was successfully treated with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution to cure these patients with difficult-to-treat infections.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Open Forum Infect Dis
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos